readthroughSign in
Aug 11, 2026Weekly roundup

J&J's TECNIS DEN00V IOL trial terminated for business reasons; results posted

Johnson & Johnson Surgical Vision posted results for a terminated Phase n/a trial of its TECNIS DEN00V intraocular lens versus a control lens in cataract patients.

This week's activity centers on a single closed-out cataract trial from Johnson & Johnson Surgical Vision.

  • The trial tested the TECNIS IOL, Model DEN00V in comparison to an aspheric monofocal IOL1 in patients with cataracts. The study was terminated, with the reason given as a business decision1, after enrolling 243 participants1. Primary completion and study completion were both listed as 2023-10-241, and results were first posted 2026-08-111. Participants were randomized in a 1:1 ratio to receive either the investigational IOL Model DEN00V or Control Model ZCB00/DCB00 in both eyes for the duration of the study1. The primary outcomes measured included monocular photopic distance-corrected intermediate visual acuity (DCIVA) in logMAR at 66 cm for first eyes1 at a 6-month time frame.

Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.